• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

医护人员耐甲氧西林金黄色葡萄球菌（MRSA）肠道携带状态成功根除——病例报告

Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker--case report.

作者信息

Leszczyński P, Weber-Dabrowska B, Kohutnicka M, Luczak M, Górecki A, Górski A

机构信息

Nosocomial Infection Control Team, The Jesus Infant Clinical Hospital, Warsaw, Poland.

出版信息

Folia Microbiol (Praha). 2006;51(3):236-8. doi: 10.1007/BF02932128.

DOI:10.1007/BF02932128
PMID:17004656
Abstract

We describe bacteriophage therapy in the case of a healthcare worker whose gastrointestinal tract was colonized by methicillin-resistant Staphylococcus aureus (MRSA) with subsequent urinary tract infection caused by the same pathogen. Oral treatment with anti-MRSA phages resulted in eradication of the carrier status.

摘要

我们描述了一名医护人员的噬菌体治疗案例，该医护人员的胃肠道被耐甲氧西林金黄色葡萄球菌（MRSA）定植，随后由同一病原体引起尿路感染。用抗MRSA噬菌体进行口服治疗后，携带者状态得以消除。

相似文献

1
Successful eradication of methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker--case report.医护人员耐甲氧西林金黄色葡萄球菌（MRSA）肠道携带状态成功根除——病例报告
Folia Microbiol (Praha). 2006;51(3):236-8. doi: 10.1007/BF02932128.
2
A neonatal specialist with recurrent methicillin-resistant Staphylococcus aureus (MRSA) carriage implicated in the transmission of MRSA to newborns.一名新生儿专科医生反复携带耐甲氧西林金黄色葡萄球菌（MRSA），这种携带情况被认为与MRSA传播给新生儿有关。
Infect Control Hosp Epidemiol. 2007 May;28(5):625-8. doi: 10.1086/513616. Epub 2007 Mar 22.
3
Overview of the risks of Staphylococcus aureus infections and their control by bacteriophages and bacteriophage-encoded products.金黄色葡萄球菌感染风险概述及其通过噬菌体和噬菌体编码产物的控制。
Braz J Microbiol. 2021 Dec;52(4):2031-2042. doi: 10.1007/s42770-021-00566-4. Epub 2021 Jul 12.
4
Transmission of methicillin-resistant Staphylococcus aureus among hospital staff in a German trauma centre: a problem without a current solution?德国一家创伤中心医院工作人员中耐甲氧西林金黄色葡萄球菌的传播：一个目前尚无解决方案的问题？
J Bone Joint Surg Br. 2007 May;89(5):642-5. doi: 10.1302/0301-620X.89B5.18756.
5
[Two hospital staff with throat carriage of methicillin-resistant Staphylococcus aureus, which had to be treated with systemic antibiotics].两名医院工作人员咽喉部携带耐甲氧西林金黄色葡萄球菌，必须接受全身抗生素治疗。
Ned Tijdschr Geneeskd. 2003 May 31;147(22):1079-81.
6
The potential of phages to prevent MRSA infections.噬菌体预防耐甲氧西林金黄色葡萄球菌感染的潜力。
Res Microbiol. 2008 Jun;159(5):400-5. doi: 10.1016/j.resmic.2008.04.003. Epub 2008 Apr 26.
7
The influence of methicillin-resistant Staphylococcus aureus (MRSA) carriers in a nursery and transmission of MRSA to their households.耐甲氧西林金黄色葡萄球菌（MRSA）携带者在托儿所中的影响以及MRSA向其家庭的传播。
J Hosp Infect. 1999 May;42(1):45-51. doi: 10.1053/jhin.1998.0551.
8
Inducible clindamycin resistance and nasal carriage rates of Staphylococcus aureus among healthcare workers and community members.医护人员和社区成员中金黄色葡萄球菌的诱导性克林霉素耐药性及鼻腔携带率。
Afr Health Sci. 2015 Sep;15(3):861-7. doi: 10.4314/ahs.v15i3.21.
9
An investigation of contact transmission of methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌接触传播的调查
J Hosp Infect. 2004 Oct;58(2):104-8. doi: 10.1016/j.jhin.2004.06.010.
10
Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.预防性屏障预防措施在烧伤病房控制耐甲氧西林金黄色葡萄球菌的医院内定植和感染中的有效性。
Am J Infect Control. 2006 Oct;34(8):476-83. doi: 10.1016/j.ajic.2006.01.011.

引用本文的文献

1
Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections.噬菌体疗法治疗胃肠道相关感染所面临挑战的最新见解。
Gut Pathog. 2025 Aug 11;17(1):60. doi: 10.1186/s13099-025-00735-y.
2
Safety and Tolerability of ShigActive™, a spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial.ShigActive™（一种靶向志贺氏菌属的噬菌体制剂）在1期随机、双盲、对照临床试验中的安全性和耐受性。
Antibiotics (Basel). 2024 Sep 7;13(9):858. doi: 10.3390/antibiotics13090858.
3
Methicillin Resistant : Molecular Mechanisms Underlying Drug Resistance Development and Novel Strategies to Combat.

本文引用的文献

1
Multiplex PCR for detection of three exfoliative toxin serotype genes in Staphylococcus aureus.用于检测金黄色葡萄球菌中三种剥脱毒素血清型基因的多重聚合酶链反应
Folia Microbiol (Praha). 2005;50(6):499-502. doi: 10.1007/BF02931437.
2
Bacteriophage translocation.噬菌体易位
FEMS Immunol Med Microbiol. 2006 Apr;46(3):313-9. doi: 10.1111/j.1574-695X.2006.00044.x.
3
Bacteriophages and transplantation tolerance.噬菌体与移植耐受
耐甲氧西林：耐药性产生的分子机制及对抗新策略
Infect Drug Resist. 2023 Dec 14;16:7641-7662. doi: 10.2147/IDR.S428103. eCollection 2023.
4
Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections.分枝杆菌噬菌体在分枝杆菌感染的诊断及替代治疗中的应用
Front Microbiol. 2023 Sep 28;14:1277178. doi: 10.3389/fmicb.2023.1277178. eCollection 2023.
5
Phage Therapy in the Management of Urinary Tract Infections: A Comprehensive Systematic Review.噬菌体疗法在尿路感染管理中的应用：一项全面的系统评价。
Phage (New Rochelle). 2023 Sep 1;4(3):112-127. doi: 10.1089/phage.2023.0024. Epub 2023 Sep 20.
6
A Century of Clinical Use of Phages: A Literature Review.噬菌体临床应用百年：文献综述
Antibiotics (Basel). 2023 Apr 13;12(4):751. doi: 10.3390/antibiotics12040751.
7
Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review.噬菌体疗法的局限性及相应的优化策略：综述
Molecules. 2022 Mar 13;27(6):1857. doi: 10.3390/molecules27061857.
8
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?21世纪的噬菌体疗法：是否有噬菌体介导疗效的现代临床证据？
Pharmaceuticals (Basel). 2021 Nov 13;14(11):1157. doi: 10.3390/ph14111157.
9
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth.用于噬菌体疗法的噬菌体鸡尾酒研发：致力于拓展活性谱的广度与深度
Pharmaceuticals (Basel). 2021 Oct 3;14(10):1019. doi: 10.3390/ph14101019.
10
Bacteriophage Capsid Modification by Genetic and Chemical Methods.噬菌体衣壳修饰的遗传和化学方法。
Bioconjug Chem. 2021 Mar 17;32(3):466-481. doi: 10.1021/acs.bioconjchem.1c00018. Epub 2021 Mar 4.
Transplant Proc. 2006 Jan-Feb;38(1):331-3. doi: 10.1016/j.transproceed.2005.12.073.
4
Phage therapy: facts and fiction.噬菌体疗法：事实与虚构
Int J Med Microbiol. 2006 Feb;296(1):5-14. doi: 10.1016/j.ijmm.2005.09.002. Epub 2005 Nov 15.
5
The use of bacteriophages in eliminating polyresistant strains of Staphylococcus aureus and Streptococcus agalactiae.噬菌体在消除耐多药金黄色葡萄球菌和无乳链球菌菌株中的应用。
Folia Microbiol (Praha). 2005;50(3):187-94. doi: 10.1007/BF02931564.
6
Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.口服大肠杆菌噬菌体T4的人类志愿者：噬菌体疗法的安全性测试。
Antimicrob Agents Chemother. 2005 Jul;49(7):2874-8. doi: 10.1128/AAC.49.7.2874-2878.2005.
7
Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections.噬菌体疗法：应对抗生素耐药性细菌感染的一个有吸引力的选择。
Drug Discov Today. 2005 Jun 15;10(12):807-9. doi: 10.1016/S1359-6446(05)03441-0.
8
MRSA--what is it, and how do we deal with the problem?耐甲氧西林金黄色葡萄球菌——它是什么，我们该如何应对这个问题？
Expert Opin Ther Targets. 2005 Apr;9(2):253-65. doi: 10.1517/14728222.9.2.253.
9
Influence of methicillin-resistant Staphylococcus aureus carrier status in liver transplant recipients.耐甲氧西林金黄色葡萄球菌携带状态对肝移植受者的影响。
Transplant Proc. 2005 May;37(4):1710-2. doi: 10.1016/j.transproceed.2005.03.136.
10
Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.多价抗葡萄球菌噬菌体K控制医院中耐抗生素葡萄球菌的潜力
Appl Environ Microbiol. 2005 Apr;71(4):1836-42. doi: 10.1128/AEM.71.4.1836-1842.2005.